Antidepressant Drug Fluoxetine Hydrochloride Pharmaceutical Material 56296-78-7

Posted on

Model NO.: 863288-34-0
Molecular Formula: C165h271n47o46
Molecular Weight: 3649.30
Einecs: 208-303-1
Specific Rotation: +27.5
Loss on Drying: ≤0.5%
Residue on Ignitio: ≤0.1%
Instructions for Use: to Make Injection, Typically 200mg/Ml
Active Life: 2-3 Days
Detection Time: 3 Weeks
Trademark: JZY
Transport Package: Discreet Package
Specification: White Powder
Origin: China
HS Code: 3002100000
Model NO.: 863288-34-0
Molecular Formula: C165h271n47o46
Molecular Weight: 3649.30
Einecs: 208-303-1
Specific Rotation: +27.5
Loss on Drying: ≤0.5%
Residue on Ignitio: ≤0.1%
Instructions for Use: to Make Injection, Typically 200mg/Ml
Active Life: 2-3 Days
Detection Time: 3 Weeks
Trademark: JZY
Transport Package: Discreet Package
Specification: White Powder
Origin: China
HS Code: 3002100000

Product Description:
CAS:56296-78-7
MF:C17H19ClF3NO
MW:345.79
EINECS:260-101-2
Product Categories:Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Serotonin;Amines;Aromatics;Isotope Labelled Compounds
Mol File:56296-78-7.mol

 
Melting point  158-159°C
storage temp.  Store at RT
CAS DataBase Reference 56296-78-7(CAS DataBase Reference)
EPA Substance Registry System Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl) phenoxy]-, hydrochloride(56296-78-7)
 
Hazard Codes  Xn,N
Risk Statements  22-38-41-50
Safety Statements  26-36/37/39-61-39
RIDADR  3249
RTECS  UI4050000
HazardClass  6.1(b)
PackingGroup  III
Hazardous Substances Data 56296-78-7(Hazardous Substances Data)


Antidepressants Fluoxetine hydrochloride Usage And Synthesis:
1.Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor (SSRI),it is adapted to the treatment of various depressive disorders, including mild or major depression, bipolar disorder depression, psychogenic depression and depressive neurosis. The mechanism is inhibiting neuronal uptake of serotonin from the synaptic cleft, increasing this neurotransmitter in the gap for practical use , thereby improving the emotional state,and treating depressive disorders.

2.Common adverse reactions are dry mouth, loss of appetite, nausea, insomnia, fatigue,  a few cases of anxiety and headaches are seen . Because fluoxetine hydrochloride has longer half-life, patients whose liver and kidney function are poor or elderly patients, should appropriately reduce the dose. Children should be applied in accordance with the doctor's advice. Patients who has the history of epilepsy, pregnancy or lactation women should use with caution . If rash or fever occurs, the drug should be discontinued immediately and symptomatic treatment should be given. It  is not appropriate to be used with monoamine oxidase inhibitor (MAOI) ; if necessary, the drug should be discontinued after five weeks, before switching to a monoamine oxidase inhibitor (MAOI).


Related Antidepressant Pharmacuetical Material:
Paroxetine 
Sertraline
Fluvoxamine maleate,
Citalopram hydrobromide,
Duloxetine hydrochloride,
Venlafaxine hydrochloride     
Duloxetine
Bupropion
Trazodone
Nefazodone
Mirtazapine
Moclobemide
Escitalopram
Gabapentin hydrochloride

Product Description:
CAS:56296-78-7
MF:C17H19ClF3NO
MW:345.79
EINECS:260-101-2
Product Categories:Intermediates & Fine Chemicals;Isotope Labeled Compounds;Pharmaceuticals;Serotonin;Amines;Aromatics;Isotope Labelled Compounds
Mol File:56296-78-7.mol

 
Melting point  158-159°C
storage temp.  Store at RT
CAS DataBase Reference 56296-78-7(CAS DataBase Reference)
EPA Substance Registry System Benzenepropanamine, N-methyl-.gamma.-[4-(trifluoromethyl) phenoxy]-, hydrochloride(56296-78-7)
 
Hazard Codes  Xn,N
Risk Statements  22-38-41-50
Safety Statements  26-36/37/39-61-39
RIDADR  3249
RTECS  UI4050000
HazardClass  6.1(b)
PackingGroup  III
Hazardous Substances Data 56296-78-7(Hazardous Substances Data)


Antidepressants Fluoxetine hydrochloride Usage And Synthesis:
1.Fluoxetine hydrochloride is a selective serotonin reuptake inhibitor (SSRI),it is adapted to the treatment of various depressive disorders, including mild or major depression, bipolar disorder depression, psychogenic depression and depressive neurosis. The mechanism is inhibiting neuronal uptake of serotonin from the synaptic cleft, increasing this neurotransmitter in the gap for practical use , thereby improving the emotional state,and treating depressive disorders.

2.Common adverse reactions are dry mouth, loss of appetite, nausea, insomnia, fatigue,  a few cases of anxiety and headaches are seen . Because fluoxetine hydrochloride has longer half-life, patients whose liver and kidney function are poor or elderly patients, should appropriately reduce the dose. Children should be applied in accordance with the doctor's advice. Patients who has the history of epilepsy, pregnancy or lactation women should use with caution . If rash or fever occurs, the drug should be discontinued immediately and symptomatic treatment should be given. It  is not appropriate to be used with monoamine oxidase inhibitor (MAOI) ; if necessary, the drug should be discontinued after five weeks, before switching to a monoamine oxidase inhibitor (MAOI).


Related Antidepressant Pharmacuetical Material:
Paroxetine 
Sertraline
Fluvoxamine maleate,
Citalopram hydrobromide,
Duloxetine hydrochloride,
Venlafaxine hydrochloride     
Duloxetine
Bupropion
Trazodone
Nefazodone
Mirtazapine
Moclobemide
Escitalopram
Gabapentin hydrochloride